Loading clinical trials...
Loading clinical trials...
A Phase II Multicenter Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma
Conditions
Interventions
Erbitux (Cetuximab)
Locations
1
United States
ImClone Investigational Site
Saint Charles, Missouri, United States
Start Date
August 1, 2002
Primary Completion Date
December 1, 2005
Completion Date
December 1, 2005
Last Updated
February 23, 2011
NCT06662786
NCT06663319
NCT05239741
NCT05770102
NCT04812912
NCT06778382
Lead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions